Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aptose Bioscns (NQ: APTO ) 0.4010 -0.0134 (-3.23%) Streaming Delayed Price Updated: 3:55 PM EDT, Sep 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 33,853 Open 0.4100 Bid (Size) 0.3960 (1) Ask (Size) 0.4100 (89) Prev. Close 0.4144 Today's Range 0.3960 - 0.4145 52wk Range 0.3316 - 3.320 Shares Outstanding 93,653,662 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Aptose Announces Results from Special Meeting of Shareholders September 05, 2024 From Aptose Biosciences, Inc. Via GlobeNewswire Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket September 03, 2024 Via Benzinga Performance YTD -83.15% -83.15% 1 Month +1.60% +1.60% 3 Month -45.81% -45.81% 6 Month -74.94% -74.94% 1 Year -86.50% -86.50% More News Read More Hello Group, Zscaler And 3 Stocks To Watch Heading Into Tuesday September 03, 2024 Via Benzinga Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib August 30, 2024 From Aptose Biosciences, Inc. Via GlobeNewswire Recap: Aptose Biosciences Q4 Earnings March 26, 2024 Via Benzinga Aptose Announces Adjournment of its Special Meeting of Shareholders August 15, 2024 From Aptose Biosciences, Inc. Via GlobeNewswire APTO Stock Earnings: Aptose Biosciences Beats EPS for Q2 2024 August 09, 2024 Via InvestorPlace Aptose Reports Results for the Second Quarter 2024 August 08, 2024 From Aptose Biosciences, Inc. Via GlobeNewswire Aptose Announces Receipt of Deficiency Notice from Nasdaq July 19, 2024 From Aptose Biosciences, Inc. Via GlobeNewswire Aptose Biosciences's Earnings: A Preview March 25, 2024 Via Benzinga Aptose Announces Results from Annual and Special Meeting of Shareholders June 18, 2024 From Aptose Biosciences, Inc. Via GlobeNewswire Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress June 14, 2024 From Aptose Biosciences, Inc. Via GlobeNewswire Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules June 03, 2024 From Aptose Biosciences, Inc. Via GlobeNewswire Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules May 31, 2024 From Aptose Biosciences, Inc. Via GlobeNewswire APTO Stock Earnings: Aptose Biosciences Beats EPS for Q1 2024 May 14, 2024 Via InvestorPlace Aptose Reports Results for the First Quarter 2024 May 14, 2024 From Aptose Biosciences, Inc. Via GlobeNewswire Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024 May 06, 2024 From Aptose Biosciences, Inc. Via GlobeNewswire APTO Stock Earnings: Aptose Biosciences Beats EPS for Q4 2023 March 26, 2024 Via InvestorPlace Aptose Reports Results for the Fourth Quarter and Full Year 2023 March 26, 2024 From Aptose Biosciences, Inc. Via GlobeNewswire Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024 March 18, 2024 From Aptose Biosciences, Inc. Via GlobeNewswire Earnings Scheduled For March 26, 2024 March 26, 2024 Via Benzinga Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option January 31, 2024 From Aptose Biosciences, Inc. Via GlobeNewswire Levi Strauss Layoffs 2024: What to Know About the Latest LEVI Job Cuts January 26, 2024 Via InvestorPlace Topics Economy Workforce Exposures Economy Layoff Why Is SU Group (SUGP) Stock Moving Today? January 26, 2024 Via InvestorPlace Topics Initial Public Offering Exposures Securities Market Why Is Aptose Biosciences (APTO) Stock Down Today? January 26, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
